SHARE

In last trading session, the stock price of Ubiquitech Software Corp (OTCMKTS:UBQU) declined more than 4% to close the trading session at $0.0400. The gains came at a massive share volume of 282,276 compared to average share volume of 119,251.

The buzz

Ubiquitech Software through its operating subsidiary firm HempLifeToday.com reported FY2015 results. The firm’s revenue surged to more than $3,000,000 from the comparable period. Ubiquitech reported that it expects continued expansion in both profitability and gross margins as its new associated program takes hold. In 1Q2016, the firm has taken several measures to strengthen its position as a pioneer in web sales of CBD oil products via CannazALL.

Ubiquitech expects that investments made in 1Q for the creation of its affiliate program will boost the company in completion of FY2016 sales target of $10,000,000. Ubiquitech expects significant margin expansion as it continues to record increased revenues supported by a lower cost structure.

Tim Zorn, the CEO of HempLife Today, said that the investment made in 1Q is another important measure toward achieving set 2016 profitability and revenue goals. The vision is clear and the focus strong as the company continues to implement business plan.

The profile

Ubiquitech Software through its subsidiary firms comes in the list of dynamic multi-media and multi-faceted companies. It deploys latest and most developed form of global internet marketing including radio, Direct Response Television, and traditional marketing, to bring traffic to the emerging and new multi-billion dollar industries, the one example which is displayed by HempLifeToday.com™.

The subsidiary focuses on the dynamic and exciting new approach in the world that acknowledges the vital health and life enriching enrichment that CBD Oil derived from the Hemp plant showcase. Through its vast network of quality USA cultivators HempLifeToday.com™ has advanced four CannazALL™ CBD oil items that include its famous CBD Tinctures, Capsules, Oils and e-liquid.

LEAVE A REPLY